The Fresh Food and Longevity Revolution: How Hong Kong’s Mylo is Redefining Pet Health Through Nutritional Science

HONG KONG — The global pet care paradigm is undergoing a seismic shift. For decades, the commercial pet food market has been dominated by ultra-processed kibble and shelf-stable dry products. However, a growing body of clinical research, coupled with a fundamental re-evaluation of nutritional standards, suggests that the traditional way we feed our dogs and cats may be quietly eroding their lifespans.

Enter Mylo, Hong Kong’s pioneering pet nutrition brand developed by the region’s first Board-Certified Veterinary Nutritionist (BCVN). Officially launched in June, Mylo has rapidly captured the attention of the veterinary community and investors alike, securing over HKD 6 million in initial funding. Backed by rigorous scientific studies—including a landmark partnership with the Hong Kong Polytechnic University and the Hong Kong Homeless Dog Shelter—Mylo is not merely selling pet food; it is engineering a comprehensive longevity support system designed to help dogs and cats live healthier lives well past the age of 20.

1. Main Facts: The Rise of a Science-Driven Pet Health Pioneer

Mylo enters the market at a time when pet owners are increasingly demanding human-grade transparency and clinical validation in pet care. Developed under the leadership of elite veterinary specialists, the brand aims to close the curtain on the age of heavily processed dry food by introducing real, functional nutrition.

The brand’s infrastructure rests on three foundational pillars:

• MyloMeals: Functional, fresh food recipes crafted to deliver real nutrition without the inflammatory drawbacks of heavy processing.
• MyloMix: Precise nutrient mixes tailored to bridge dietary gaps and optimize metabolic health.
• MyloBiome: Advanced functional probiotic formulas clinically proven to dramatically alter the gut microbiome.

Beyond its commercial product lineup, Mylo has made waves in the medical research community. A recent 16-week collaborative study with Hong Kong Polytechnic University and the Hong Kong Homeless Dog Shelter revealed that MyloBiome successfully inhibits 95% of harmful bacteria in canine guts, strengthening intestinal mucosal barriers and systemic immunity.

To capitalize on these findings, Mylo is launching Asia’s largest canine fecal microbiota database and longitudinal research program, utilizing non-invasive stool diagnostics to detect severe conditions like Chronic Kidney Disease (CKD) early. To steer this ambitious roadmap, the company has appointed Sylvia Burbery—former Regional President of Royal Canin Asia Pacific & Emerging Markets—as a board advisor.

2. Chronology: The Journey to Market Leadership

The trajectory of Mylo’s development reflects a meticulous, science-first approach that bridges academic research with commercial application:

• Pre-Launch R&D Phase: Dr. Moran Tal-Gavriel, holding European Board of Veterinary Specialisation (EBVS) certification, spearheaded the formulation of Mylo’s core recipes. Recognizing that true veterinary nutritionists represent less than 0.01% of global veterinary professionals, Dr. Tal-Gavriel worked alongside a resident veterinary team to design products focused on disease prevention rather than mere sustenance.
• The 16-Week Microbiome Study: In collaboration with Professor William Tai of Hong Kong Polytechnic University and the Hong Kong Homeless Dog Shelter, Mylo initiated a comprehensive trial evaluating the impact of its functional probiotic formulas (MyloBiome) on shelter dogs, establishing baseline data for gut health optimization.
• June Official Launch & Funding Milestone: Mylo officially launched in the Hong Kong market, successfully closing over HKD 6 million in initial funding from medical and venture capital backers impressed by its clinical validation.
• Post-Launch Clinical Expansion: Following its market entry, Mylo announced its partnership with local veterinary clinics to build Asia’s largest canine longitudinal stool bank. Concurrently, industry veteran Sylvia Burbery joined the board to orchestrate regional expansion across the Asia-Pacific region.

3. Supporting Data: The Science of Fresh Food and Gut Health

Mylo’s product philosophy is anchored in contemporary nutritional science, drawing sharp contrasts between processed diets and fresh, whole-food alternatives.

The Problem with Ultra-Processed Kibble

Global nutritional science is experiencing a paradigm shift. The Dietary Guidelines for Americans (2025–2030) introduced an "inverted pyramid" concept, emphasizing the fundamental rule to "eat real food" and fundamentally rewriting human nutritional standards.

Pet nutrition is following suit. A landmark one-year duration study published by Cornell University in 2025 discovered that dogs fed dry food long-term accumulate significantly higher levels of Advanced Glycation End products (AGEs). These compounds are directly linked to chronic systemic inflammation, accelerated cellular aging, and degenerative diseases. Conversely, dogs transitioned to fresh food diets for just one month exhibited profound metabolic improvements, marked by substantial increases in antioxidant activity and cell-protection indicators.

The Gut-Immunity Axis

Mylo’s clinical data underscores the critical role of the microbiome in canine longevity. With over 70% of an animal’s immune cells residing in and around the gastrointestinal tract, gut health dictates everything from digestion and skin condition to mood and the pace of biological aging.

Data from the 16-week MyloBiome study demonstrated that precise functional probiotic interventions can inhibit up to 95% of bad bacteria in the canine gut. This dramatic shift creates a resilient intestinal mucosal barrier, laying the groundwork for robust lifelong immunity.

4. Official Responses: Insights from the Leadership Team

The driving force behind Mylo is a multidisciplinary team of clinicians, researchers, and corporate leaders committed to shifting veterinary care from reactive treatment to proactive prevention.

• Kingson Kwan, Founder of Mylo:

  "Feeding dogs dry food every day is equivalent to letting children eat instant noodles paired with luncheon meat and eggs every day, then saying the presence of meat and eggs makes it a healthy diet. When global nutrition guidelines sound the alarm on heavily processed food, we must apply those same nutritional standards for our furry friends. Mylo’s debut is to close the curtain on the age of dry food, and let dogs and cats enjoy real food, real nutrition."

  Kwan further emphasized the overarching vision of the brand:

  "The core of longevity is nutritional health and gut health, the exact two large domains Mylo is focusing on. We’ve assembled a scientific advisory team of BCVNs, university research teams, professors, and veterinarians to develop our products. Our vision is clear and simple—hoping to see more dogs live past the age of 20."

• Dr. Moran Tal-Gavriel, Chief Veterinary Nutrition Director:

  "My initial goal developing Mylo was to bring truly functional nutritional products to Asia, and make it the top choice for disease prevention. Each bowl from Mylo is made through precise calculation to turn nutrition into preventive care, and establish a sustainable health foundation for dogs."

• Professor William Tai, Chief Scientific Officer at MyloLab and Professor at Hong Kong Polytechnic University:

  "A balanced gut microbiota is the key to gut microbiome health. The data of this 16-week study proves that precise functional probiotic formulas can effectively improve and balance gut microbiota, establishing a solid foundation for dogs’ overall health."

• Dr. Samson Lui, Co-Founder and Registered Veterinarian:

  "Seeing several sick dogs in the clinic every day, I’ve always hoped for a preventive measure that can protect them from illnesses. By incorporating Mylo’s comprehensive nutritional support system and early screening tests, we can intervene early to truly extend their healthy lifespan. To expel illness, and welcome healthier years."

• Sylvia Burbery, Board Advisor and Former President of Royal Canin Asia Pacific & Emerging Markets:

  "Establishing and expanding a science-based pet nutrition brand sure is a challenge. In terms of propelling business growth in Asia-Pacific and organizing market expansion, Sylvia [Burbery] has incomparable experience. Her addition not only strengthens Mylo’s leadership team but places a stronger focus on propelling our local scientific research results towards the broader Asia-Pacific market."

5. Implications: Redefining the Future of Pet Care in Asia and Beyond

The emergence of Mylo signals a broader transformation in how pet parents and medical professionals view animal wellness. By introducing Board-Certified Veterinary Nutrition expertise to a market frequently saturated by marketing buzzwords, Mylo sets a new clinical benchmark.

Shifting from Treatment to Prevention

The establishment of Asia’s largest canine longitudinal stool bank represents a major leap forward in non-invasive diagnostics. By leveraging stool samples to monitor microbiome shifts and detect early markers of conditions like Chronic Kidney Disease (CKD), veterinarians can execute therapeutic interventions long before clinical symptoms manifest. This proactive approach has the potential to dramatically reduce veterinary emergency visits, alleviate chronic pain in aging animals, and substantially expand median life expectancies.

Commercial and Regional Expansion

With the strategic addition of Sylvia Burbery—whose three decades of multinational pet care leadership at Mars and Royal Canin helped build some of the world’s most recognizable pet brands—Mylo is uniquely positioned to scale its operations. The brand’s early success in securing HKD 6 million in funding proves that investors recognize the commercial viability of evidence-based, human-grade pet nutrition.

As pet humanization trends accelerate across Asia, Mylo’s integrated ecosystem—combining fresh functional meals (MyloMeals), precise nutrient science (MyloMix), advanced microbiome formulas (MyloBiome), and continuous academic research—offers a compelling blueprint for the future of veterinary medicine. For dogs and cats across the region, the curtain is finally closing on the era of processed kibble, opening the door to a healthier, longer, and more vibrant lease on life.